跳至主要内容
临床试验/NCT00910325
NCT00910325终止1 期

Natural Orifice Translumenal Endoscopic Surgery: Laparoscopic-Assisted Transvaginal Cholecystectomy

Massachusetts General Hospital2 个研究点 分布在 1 个国家目标入组 3 人开始时间: 2008年11月1日最近更新:
适应症

试验速览

阶段
1 期
状态
终止
入组人数
3
试验地点
2
主要终点
The safety and efficacy of the procedure

研究概览

简要总结

To determine the feasibility, safety, and efficacy of a novel minimally invasive approach to cholecystectomy and to establish a description of this novel translumenal technique in humans at this institution.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
26 Years 至 64 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Females who are postmenopausal or who no longer wish to bear children
  • Females >25 years old and <65 years old
  • Diagnosis of biliary disease requiring cholecystectomy
  • American Society of Anesthesiology (ASA) Class I or II
  • Females who are able to understand and willing to sign an informed consent document

排除标准

  • Pregnancy
  • BMI >= 30
  • Patients who are still interested in childbearing
  • Patients taking immunosuppressive medications or who are immunocompromised
  • Patients with acute cholecystitis or history of acute cholecystitis ( as defined by right upper quadrant pain with history of fevers and/or elevated white blood cell count and/or positive ultrasound findings, ie, gallbladder wall thickening or pericholecystic fluid)
  • Patients with suspicion of gallbladder cancer
  • Patients with history of previous open abdominal surgery
  • Patients with untreated common bile duct stones

结局指标

主要结局

The safety and efficacy of the procedure

时间窗: one year

次要结局

  • Post-operative pain(one year)
  • Time to return to work(one year)
  • Time to return to daily activities(one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

David W. Rattner, MD

Chief, Division of General and Gastrointestinal Surgery

Massachusetts General Hospital

研究点 (2)

Loading locations...

相似试验